GB Patent

GB2141342A — Long-acting formulation of cefaclor

Assigned to Shionogi and Co Ltd · Expires 1984-12-19 · 41y expired

What this patent protects

Highly potent long-acting formulations of cefaclor for treating bacterial infections in humans or other animals comprise a rapid-release component and a slow-release component in a ratio of about 3:7 to about 5:5 by potency of cefaclor. Such formulations are convenient for admini…

USPTO Abstract

Highly potent long-acting formulations of cefaclor for treating bacterial infections in humans or other animals comprise a rapid-release component and a slow-release component in a ratio of about 3:7 to about 5:5 by potency of cefaclor. Such formulations are convenient for administration or carrying about.

Drugs covered by this patent

methylphenidate-hydrochloride (METHYLPHENIDATE HYDROCHLORIDE)

Patent Metadata

Patent number: GB2141342A
Jurisdiction: GB
Classification: —
Expires: 1984-12-19
Drug substance claim: No
Drug product claim: No
Assignee: Shionogi and Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.